Imaging in Clinical Trials:
Pitfalls and Promises
About this webinar
Imaging holds great promise for clinical trials in all phases. In early phase trials it can provide a direct window into drug effects, proving or disproving the mechanism of action while detecting if there is an efficacy signal. For registration trials it is the quickest path to the pharmacy shelf.
In this webinar, attendees will learn how Philips Pharma Solutions, formerly BioTel Research, applies more than 20 years of imaging science and operational expertise to identify and manage the inherent risks to capturing complete and high-quality central review data of study endpoints, unlocking its full potential.
Register to understand the importance of imaging and the best practices to support successful central review of data to prove endpoint.
Who should attend
- Clinical Researchers
- Clinical Development
- Clinical Operations
- Project Management
- Procurement Leads
- Medical/Scientific Leads
What you will learn
- The role of imaging in clinical trials
- Selection of modalities and their potential operational risks
- Right-sized training methods for sites designed to manage risk to capturing complete and quality data
- Best practices to support successful central review of data to prove endpoints
Featured Speakers
Ed Ashton
Ed Ashton serves as the Vice President of Oncology Imaging for Philips Pharma Solutions. In this role, he has provided technical leadership in more than 200 clinical trials in oncology, neurology and cardiology over the past 20 years. Dr. Ashton is a frequent speaker at international imaging conferences and has authored many peer-reviewed publications describing his research. Prior to joining BioTel Research, Dr. Ashton was a Lead Signal Processing Engineer at The MITRE Corporation in McLean, VA. Earlier in his career, he spent three years as a Research Engineer with the Naval Research Laboratory, where he received the Alan Berman Research Publication Award and was nominated for the Edison Award for Applied Science.
Alan Soanes
Alan Soanes is the Director of Feasibility for Philips Pharma Solutions. In this role, he oversees and facilitates cross-functional feasibility analysis and solutions development for new and existing business. Alan has held diverse leadership roles in his 12 years with Philips Pharma Solutions, within project management, account management, product management and now in business development. Alan leverages his operational experience and acumen to identify and proactively manage risk, developing solutions that support collaborative partnerships with customers and running successful clinical trials.
Partner for this event
Philips Pharma Solutions
Philips Pharma Solutions, formerly BioTel Research, is an industry leader in medical imaging and cardiovascular safety testing for clinical trials. Philips Pharma Solutions offers global operational support for cardiovascular monitoring in all therapeutic areas, and advanced imaging services in oncology, cardiovascular, metabolic, musculoskeletal, neurologic, and medical device studies. Their experienced research team comprises key opinion leaders, board-certified cardiologists and radiologists, sub-specialty scientists, and highly trained technicians — who acquire, evaluate, and report high-quality data through an efficient, cloud-based infrastructure. Many biopharmaceutical trial sponsors rely on our scientific leaders to help design and optimize their protocols and statistical analysis plans. We have conducted clinical trials contributing to the market approval of nearly 100 new drugs to date.